CEO of Zoetis Inc (30-Year Financial, Insider Trades) Juan Ramon Alaix (insider trades) sold 50,000 shares of ZTS on 11/19/2019 at an average price of $119.13 a share. The total sale was $6 million.
Zoetis Inc is a developer and manufacturer of drugs providing medicines for animal health, and vaccines for livestock and companion animals. Its products are anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. Zoetis Inc has a market cap of $56.95 billion; its shares were traded at around $119.56 with a P/E ratio of 39.46 and P/S ratio of 9.41. The dividend yield of Zoetis Inc stocks is 0.55%. Zoetis Inc had annual average EBITDA growth of 19.80% over the past five years. GuruFocus has detected 1 severe warning sign with Zoetis Inc. .
CEO Recent Trades:
- CEO Juan Ramon Alaix sold 50,000 shares of ZTS stock on 11/19/2019 at the average price of $119.13. The price of the stock has increased by 0.36% since.
Directors and Officers Recent Trades:
- Executive Vice President Roxanne Lagano sold 4,463 shares of ZTS stock on 11/19/2019 at the average price of $118.99. The price of the stock has increased by 0.48% since.
- Executive Vice President Heidi C. Chen sold 11,425 shares of ZTS stock on 11/18/2019 at the average price of $118.86. The price of the stock has increased by 0.59% since.
- Executive Vice President Clinton A. Jr. Lewis sold 6,123 shares of ZTS stock on 11/14/2019 at the average price of $116.13. The price of the stock has increased by 2.95% since.
- Executive Vice President Kristin C Peck sold 11,500 shares of ZTS stock on 11/12/2019 at the average price of $117.16. The price of the stock has increased by 2.05% since.
For the complete insider trading history of ZTS, click here
.
